Skip to main content
SpringerLink
Log in

Prevalence of USP and hlyA Genes and Association with Drug Resistance in Uropathogenic Escherichia coli Isolated from Patients in a Tertiary Hospital from Southeast China

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

E. coli was cultured from the urine of patients from the tertiary hospital located in Southeast China from 2017 to 2019. The species were identified, drug sensitivity test was performed, and the presence of the virulence genes USP and hlyA was determined. A total of 483 strains of E. coli were isolated, including 132 from patients with urinary tract infection (UTI). The resistance to ciprofloxacin was more common in non-UTI patients, while resistance to gentamycin was significantly higher in the UTI group. In the UTI group, the proportions of isolated bacteria with the virulence USP (40.15%) and hlyA (8.33%) genes were significantly higher than in the non-UTI group (19.60 and 2.56%, respectively). The rate of resistance of E. coli toward levofloxacin in the USP+ group was significantly (p<0.05) higher than in the USP— group. Thus, we revealed the differences in the rate of drug resistance and prevalence of USP and hlyA between the UTI and non-UTI groups. Furthermore, the presence of the USP gene was found to be associated with greater resistance to levofloxacin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kot B. Antibiotic Resistance Among Uropathogenic Escherichia coli. Pol. J. Microbiol. 2019;68(4):403-415. doi: https://doi.org/10.33073/pjm-2019-048

    Article  Google Scholar 

  2. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015;13(5):269-84. doi: https://doi.org/10.1038/nrmicro3432

    Article  CAS  Google Scholar 

  3. Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front. Microbiol. 2017 15;8:1566. doi: https://doi.org/10.3389/fmicb.2017.01566

    Article  Google Scholar 

  4. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 31st ed. CLSI Supplement M100. CLSI, 2021.

  5. Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern. Med. 2013;173(1):62-68. doi: https://doi.org/10.1001/2013.jamainternmed.829

    Article  Google Scholar 

  6. Armstrong ES, Mikulca JA, Cloutier DJ, Bliss CA, Steenbergen JN. Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections. BMC Infect. Dis. 2016;16(1):710. doi: https://doi.org/10.1186/s12879-016-2057-2

    Article  CAS  Google Scholar 

  7. Sun J, Du L, Yan L, Dai W, Wang Z, Xu X. Eight-Year Surveillance of Uropathogenic Escherichia coli in Southwest China. Infect. Drug Resist. 2020;13:1197-1202. doi: https://doi.org/10.2147/IDR.S250775

    Article  CAS  Google Scholar 

  8. Paniagua-Contreras GL, Monroy-Pérez E, Rodríguez-Moctezuma JR, Domínguez-Trejo P, Vaca-Paniagua F, Vaca S. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. J. Microbiol. Immunol. Infect. 2017;50(4):478-485. doi: https://doi.org/10.1016/j.jmii.2015.08.005

    Article  Google Scholar 

  9. Baldiris-Avila R, Montes-Robledo A, Buelvas-Montes Y. Phylogenetic Classification, Biofilm-Forming Capacity, Virulence Factors, and Antimicrobial Resistance in Uropathogenic Escherichia coli (UPEC). Curr. Microbiol. 2020;77(11):3361-3370. doi: https://doi.org/10.1007/s00284-020-02173-2

    Article  CAS  Google Scholar 

  10. Dong M, Zheng SF, Yu Z, Chen X, Yang Q, Kong HS, Yu XZ, Huang Z, Chen Z. The high prevalence of some uropathogenic Escherichia coli clonal groups with enhanced virulence and antimicrobial resistance. Chin. J. Lab. Med. 2014;(7):531-534.

    Google Scholar 

  11. Ejrnæs K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan. Med. Bull. 2011;58(4):B4187.

    Google Scholar 

  12. Garcia TA, Ventura CL, Smith MA, Merrell DS, O’Brien AD. Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder. Infect. Immun. 2013;81(1):99-109. doi: https://doi.org/10.1128/IAI.00605-12

    Article  CAS  Google Scholar 

  13. Lu Y, Rafiq A, Zhang Z, Aslani F, Fijak M, Lei T, Wang M, Kumar S, Klug J, Bergmann M, Chakraborty T, Meinhardt A, Bhushan S. Uropathogenic Escherichia coli virulence factor hemolysin A causes programmed cell necrosis by altering mitochondrial dynamics. FASEB J. 2018;32(8):4107-4120. doi: https://doi.org/10.1096/fj.201700768R

    Article  CAS  Google Scholar 

  14. Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob. Resist. Infect. Control. 2018;7:118. doi: https://doi.org/10.1186/s13756-018-0411-4

    Article  Google Scholar 

  15. Wang Y, Zhao S, Han L, Guo X, Chen M, Ni Y, Zhang Y, Cui Z, He P. Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China. J. Antibiot. (Tokyo). 2014;67(12):799-805. doi: https://doi.org/10.1038/ja.2014.72

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China

    G. Li, S. Wang, S. Zhao, Y. Zhou & S. Jin

  2. Department of Biomedical Sciences Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China

    X. Pan

Authors
  1. G. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. X. Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to X. Pan.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 174, No. 7, pp. 68-73, July, 2022

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, G., Wang, S., Zhao, S. et al. Prevalence of USP and hlyA Genes and Association with Drug Resistance in Uropathogenic Escherichia coli Isolated from Patients in a Tertiary Hospital from Southeast China. Bull Exp Biol Med 174, 57–61 (2022). https://doi.org/10.1007/s10517-022-05648-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-022-05648-3

Key Words

Search

Navigation